Cargando…
Human iPSCs and Genome Editing Technologies for Precision Cardiovascular Tissue Engineering
Induced pluripotent stem cells (iPSCs) originate from the reprogramming of adult somatic cells using four Yamanaka transcription factors. Since their discovery, the stem cell (SC) field achieved significant milestones and opened several gateways in the area of disease modeling, drug discovery, and r...
Autores principales: | Gähwiler, Eric K. N., Motta, Sarah E., Martin, Marcy, Nugraha, Bramasta, Hoerstrup, Simon P., Emmert, Maximilian Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273765/ https://www.ncbi.nlm.nih.gov/pubmed/34262897 http://dx.doi.org/10.3389/fcell.2021.639699 |
Ejemplares similares
-
MSCs vs. iPSCs: Potential in therapeutic applications
por: Thanaskody, Kalaiselvaan, et al.
Publicado: (2022) -
Combining Cell Technologies With Biomimetic Tissue Engineering Applications: A New Paradigm for Translational Cardiovascular Therapies
por: Motta, Sarah E, et al.
Publicado: (2023) -
Pannexin 1 Influences Lineage Specification of Human iPSCs
por: Noort, Rebecca J., et al.
Publicado: (2021) -
Content and Method of Information for Participants in Clinical Studies With Induced Pluripotent Stem Cells (iPSCs)
por: Orzechowski, Marcin, et al.
Publicado: (2021) -
Creation of GMP-Compliant iPSCs From Banked Umbilical Cord Blood
por: Tian, Pei, et al.
Publicado: (2022)